Category: research
-
The importance of early diagnosis
Alport UK Chief Executive Susie Gear has written a new article for Nature Reviews Nephrology, highlighting why earlier diagnosis of rare kidney diseases can make such a difference to people’s lives.
-
A new perspective on Alport naming
For many years, Alport syndrome was considered a very rare condition affecting a relatively small number of people. A new perspective published in the Journal of the American Society of Nephrology (JASN) challenges this view.
-
RaDaR is 15
About 1200 Alport patients are registered in the Alport cohort in the UK’s really impressive Rare Renal Disease Registry (RaDaR). This event (22 May 2025) was an occasion in London to meet with other rare disease groups, and celebrate the tremendous resource that RaDaR has become. We hope for a significant publication from the Alport…
-
Are Flozins a treatment breakthrough for Alport syndrome?
Listen to Professor Richard Haynes of Public engagement at Nuffield Department of Population Health inviting you to join our next online workshop on Tuesday 5 January at 7pm GMT to find out more about SGLT2 inhibitors/Flozins and kidney health. Previously used in the treatment of diabetes, SGLT2 Inhibitors/Flozins, approved for use in kidney patients, could be a treatment breakthrough…
-
The implantable bio-artifical kidney
A very interesting piece of research brought to us by one of our Edinburgh Meeting attendees Derek Keen. He has just accomplished 30 years on dialysis. A 3 minute video about a device which will transform the lives of many. The implantable bio-artificial kidney is a new way forward for renal treatment. Trials start in…
-
New Research in Manchester funded by KRUK
There is exciting new research being done in Manchester by Dr Michael Randles and Sophie Collinson. A two year project funded by Kidney Research UK Dr Michael Randles, 25 I studied biochemistry at the University of Bristol and have…
-
correction of the genetic defect in Alport syndrome using the TALEN approach
One of two projects recently funded by Alport Syndrome Foundation (USA). see article